1
|
Ben Boina N, Mossé B, Baudot A, Remy E. Refining Boolean models with the partial most permissive scheme. Bioinformatics 2025; 41:btaf123. [PMID: 40119940 PMCID: PMC12021794 DOI: 10.1093/bioinformatics/btaf123] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2024] [Revised: 03/07/2025] [Accepted: 03/20/2025] [Indexed: 03/25/2025] Open
Abstract
MOTIVATION In systems biology, modeling strategies aim to decode how molecular components interact to generate dynamical behavior. Boolean modeling is more and more used, but the description of the dynamics generated by discrete variables with only two values may be too limited to capture certain dynamical properties. Multivalued logical models can overcome this limitation by allowing more than two levels for each component. However, multivaluing a Boolean model is challenging. RESULTS We present MRBM, a method for efficiently identifying the components of a Boolean model to be multivalued in order to capture specific fixed-point reachabilities in the asynchronous dynamics. To this goal, we defined a new updating scheme locating reachability properties in the most permissive dynamics. MRBM is supported by mathematical demonstrations and illustrated on a toy model and on two models of stem cell differentiation. AVAILABILITY AND IMPLEMENTATION The MRBM method and the BMs used in this article are available on GitHub at: https://github.com/NdnBnBn/MRBM, and archived in Zenodo (doi: 10.5281/ZENODO.14979798).
Collapse
Affiliation(s)
- Nadine Ben Boina
- Aix Marseille Univ, CNRS, I2M (UMR 7373), Turing Center for Living systems, Marseille, France
- Aix Marseille Univ, INSERM, MMG, Marseille, France
| | - Brigitte Mossé
- Aix Marseille Univ, CNRS, I2M (UMR 7373), Turing Center for Living systems, Marseille, France
| | - Anaïs Baudot
- Aix Marseille Univ, INSERM, MMG, Marseille, France
- CNRS, Marseille, France
- Barcelona Supercomputing Centre, Barcelona, Spain
| | - Elisabeth Remy
- Aix Marseille Univ, CNRS, I2M (UMR 7373), Turing Center for Living systems, Marseille, France
| |
Collapse
|
2
|
Sánchez-Villanueva JA, N’Guyen L, Poplineau M, Duprez E, Remy É, Thieffry D. Predictive modelling of acute Promyelocytic leukaemia resistance to retinoic acid therapy. Brief Bioinform 2024; 26:bbaf002. [PMID: 39807666 PMCID: PMC11729720 DOI: 10.1093/bib/bbaf002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2024] [Revised: 12/09/2024] [Indexed: 01/16/2025] Open
Abstract
Acute Promyelocytic Leukaemia (APL) arises from an aberrant chromosomal translocation involving the Retinoic Acid Receptor Alpha (RARA) gene, predominantly with the Promyelocytic Leukaemia (PML) or Promyelocytic Leukaemia Zinc Finger (PLZF) genes. The resulting oncoproteins block the haematopoietic differentiation program promoting aberrant proliferative promyelocytes. Retinoic Acid (RA) therapy is successful in most of the PML::RARA patients, while PLZF::RARA patients frequently become resistant and relapse. Recent studies pointed to various underlying molecular components, but their precise contributions remain to be deciphered. We developed a logical network model integrating signalling, transcriptional, and epigenetic regulatory mechanisms, which captures key features of the APL cell responses to RA depending on the genetic background. The explicit inclusion of the histone methyltransferase EZH2 allowed the assessment of its role in the resistance mechanism, distinguishing between its canonical and non-canonical activities. The model dynamics was thoroughly analysed using tools integrated in the public software suite maintained by the CoLoMoTo consortium (https://colomoto.github.io/). The model serves as a solid basis to assess the roles of novel regulatory mechanisms, as well as to explore novel therapeutical approaches in silico.
Collapse
MESH Headings
- Leukemia, Promyelocytic, Acute/drug therapy
- Leukemia, Promyelocytic, Acute/genetics
- Leukemia, Promyelocytic, Acute/metabolism
- Leukemia, Promyelocytic, Acute/pathology
- Tretinoin/therapeutic use
- Tretinoin/pharmacology
- Humans
- Drug Resistance, Neoplasm/genetics
- Enhancer of Zeste Homolog 2 Protein/genetics
- Enhancer of Zeste Homolog 2 Protein/metabolism
- Antineoplastic Agents/therapeutic use
- Epigenesis, Genetic
- Models, Biological
- Retinoic Acid Receptor alpha/genetics
- Signal Transduction/drug effects
Collapse
Affiliation(s)
| | - Lia N’Guyen
- Integrative molecular biology in hematopoiesis and leukemia, Equipe Labellisée Ligue Contre le Cancer, CRCM, Inserm UMR1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix Marseille Univ, 27 Bd Lei Roure, 13009 Marseille, France
| | - Mathilde Poplineau
- Integrative molecular biology in hematopoiesis and leukemia, Equipe Labellisée Ligue Contre le Cancer, CRCM, Inserm UMR1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix Marseille Univ, 27 Bd Lei Roure, 13009 Marseille, France
| | - Estelle Duprez
- Integrative molecular biology in hematopoiesis and leukemia, Equipe Labellisée Ligue Contre le Cancer, CRCM, Inserm UMR1068, CNRS UMR7258, Institut Paoli-Calmettes, Aix Marseille Univ, 27 Bd Lei Roure, 13009 Marseille, France
| | - Élisabeth Remy
- Aix Marseille Université, CNRS, I2M, 163 avenue de Luminy, 13009 Marseille, France
| | - Denis Thieffry
- Department of Biology, École Normale Supérieure, 46 rue d'Ulm, 75005 Paris, France
- Institut Curie - INSERM U900 - Mines Paris, PSL Research University, 26 rue d'Ulm, 75005 Paris, France
| |
Collapse
|
3
|
Hernandez C, Thomas-Chollier M, Naldi A, Thieffry D. Computational Verification of Large Logical Models-Application to the Prediction of T Cell Response to Checkpoint Inhibitors. Front Physiol 2020; 11:558606. [PMID: 33101049 PMCID: PMC7554341 DOI: 10.3389/fphys.2020.558606] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2020] [Accepted: 08/19/2020] [Indexed: 12/31/2022] Open
Abstract
At the crossroad between biology and mathematical modeling, computational systems biology can contribute to a mechanistic understanding of high-level biological phenomenon. But as knowledge accumulates, the size and complexity of mathematical models increase, calling for the development of efficient dynamical analysis methods. Here, we propose the use of two approaches for the development and analysis of complex cellular network models. A first approach, called "model verification" and inspired by unitary testing in software development, enables the formalization and automated verification of validation criteria for whole models or selected sub-parts. When combined with efficient analysis methods, this approach is suitable for continuous testing, thereby greatly facilitating model development. A second approach, called "value propagation," enables efficient analytical computation of the impact of specific environmental or genetic conditions on the dynamical behavior of some models. We apply these two approaches to the delineation and the analysis of a comprehensive model for T cell activation, taking into account CTLA4 and PD-1 checkpoint inhibitory pathways. While model verification greatly eases the delineation of logical rules complying with a set of dynamical specifications, propagation provides interesting insights into the different potential of CTLA4 and PD-1 immunotherapies. Both methods are implemented and made available in the all-inclusive CoLoMoTo Docker image, while the different steps of the model analysis are fully reported in two companion interactive jupyter notebooks, thereby ensuring the reproduction of our results.
Collapse
Affiliation(s)
- Céline Hernandez
- Institut de Biologie de l'ENS (IBENS), Département de Biologie, École Normale Supérieure, CNRS, INSERM, Université PSL, Paris, France
| | - Morgane Thomas-Chollier
- Institut de Biologie de l'ENS (IBENS), Département de Biologie, École Normale Supérieure, CNRS, INSERM, Université PSL, Paris, France.,Institut Universitaire de France, Paris, France
| | - Aurélien Naldi
- Institut de Biologie de l'ENS (IBENS), Département de Biologie, École Normale Supérieure, CNRS, INSERM, Université PSL, Paris, France
| | - Denis Thieffry
- Institut de Biologie de l'ENS (IBENS), Département de Biologie, École Normale Supérieure, CNRS, INSERM, Université PSL, Paris, France
| |
Collapse
|
4
|
Schwab JD, Kühlwein SD, Ikonomi N, Kühl M, Kestler HA. Concepts in Boolean network modeling: What do they all mean? Comput Struct Biotechnol J 2020; 18:571-582. [PMID: 32257043 PMCID: PMC7096748 DOI: 10.1016/j.csbj.2020.03.001] [Citation(s) in RCA: 84] [Impact Index Per Article: 16.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2019] [Revised: 01/27/2020] [Accepted: 03/01/2020] [Indexed: 12/02/2022] Open
Abstract
Boolean network models are one of the simplest models to study complex dynamic behavior in biological systems. They can be applied to unravel the mechanisms regulating the properties of the system or to identify promising intervention targets. Since its introduction by Stuart Kauffman in 1969 for describing gene regulatory networks, various biologically based networks and tools for their analysis were developed. Here, we summarize and explain the concepts for Boolean network modeling. We also present application examples and guidelines to work with and analyze Boolean network models.
Collapse
Affiliation(s)
- Julian D Schwab
- Institute of Medical Systems Biology, Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany
| | - Silke D Kühlwein
- Institute of Medical Systems Biology, Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany
| | - Nensi Ikonomi
- Institute of Medical Systems Biology, Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany
| | - Michael Kühl
- Institute of Biochemistry and Molecular Biology, Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany
| | - Hans A Kestler
- Institute of Medical Systems Biology, Ulm University, Albert-Einstein-Allee 11, 89081 Ulm, Germany
| |
Collapse
|